Proteogenomic profiling of acute myeloid leukemia to identify therapeutic targets
HC Murray, J Sillar, M Chambers… - Expert Review of …, 2024 - Taylor & Francis
Introduction Acute myeloid leukemia (AML) is an aggressive and poor-prognosis blood
cancer. Despite a low mutation burden compared to other cancers, AML is heterogenous …
cancer. Despite a low mutation burden compared to other cancers, AML is heterogenous …